1 Charité-Universitätsmedizin Berlin, Berlin, Germany [email protected]
2 University Hospital Freiburg, Freiburg, Germany
Drs. Schrezenmeier and Budde report receiving grant support from Alexion Pharmaceuticals; and Dr. Bergmann, receiving speaker fees from Alexion Pharmaceuticals, being an employee of a medical diagnostic laboratory offering genetic testing, and receiving research support for his laboratory from the Deutsche Forschungsgemeinschaft (German Research Foundation) Collaborative Research Center KIDGEM 1140 (project 246781735) and the German Federal Ministry of Education and Research (01GM1515). No other potential conflict of interest relevant to this letter was reported.
